We are live on ! Find out more
TNDM icon

Tandem Diabetes Care

66 hedge funds and large institutions have $160M invested in Tandem Diabetes Care in 2014 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 21 increasing their positions, 21 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 21

2% less call options, than puts

Call options by funds: $1.27M | Put options by funds: $1.29M

7% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 14

4% less funds holding

Funds holding: 6966 (-3)

5% less capital invested

Capital invested by funds: $170M → $160M (-$9.2M)

Holders
66
Holders Change
-3
Holders Change %
-4.35%
% of All Funds
1.76%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
13
Increased
21
Reduced
21
Closed
14
Calls
$1.27M
Puts
$1.29M
Net Calls
-$20K
Net Calls Change
+$493K
Name Holding Trade Value Shares
Change
Change in
Stake
Westfield Capital Management
26
Westfield Capital Management
Massachusetts
$1.13M +$1.23M +8,871 New
GIP
27
Granite Investment Partners
California
$845K -$842K -6,073 -48%
BIT
28
BlackRock Institutional Trust
California
$843K -$20.5K -148 -2%
New York State Common Retirement Fund
29
New York State Common Retirement Fund
New York
$837K
Deutsche Bank
30
Deutsche Bank
Germany
$782K +$54.1K +390 +7%
Geode Capital Management
31
Geode Capital Management
Massachusetts
$776K +$25.1K +181 +3%
Ameriprise
32
Ameriprise
Minnesota
$775K +$3.6K +26 +0.4%
William Blair & Company
33
William Blair & Company
Illinois
$773K -$110K -791 -12%
SKK
34
Shepherd Kaplan Krochuk
Massachusetts
$444K
Ohio Public Employees Retirement System (OPERS)
35
Ohio Public Employees Retirement System (OPERS)
Ohio
$393K
PSC
36
Piper Sandler & Co
Minnesota
$381K +$134K +970 +48%
TCIM
37
TIAA CREF Investment Management
New York
$377K -$31.1K -224 -7%
Charles Schwab
38
Charles Schwab
California
$363K +$114K +824 +41%
Luther King Capital Management (LKCM)
39
Luther King Capital Management (LKCM)
Texas
$330K
JMPWA
40
JP Morgan Private Wealth Advisors
California
$318K
BIM
41
BlackRock Investment Management
Delaware
$310K +$1.25K +9 +0.4%
ARTA
42
A.R.T. Advisors
New York
$260K +$284K +2,050 New
Susquehanna International Group
43
Susquehanna International Group
Pennsylvania
$239K +$261K +1,879 New
CS
44
Credit Suisse
Switzerland
$221K +$242K +1,742 New
HCM
45
Highbridge Capital Management
New York
$218K -$77.8K -561 -25%
California State Teachers Retirement System (CalSTRS)
46
California State Teachers Retirement System (CalSTRS)
California
$196K +$832 +6 +0.4%
KeyBank National Association
47
KeyBank National Association
Ohio
$173K +$416 +3 +0.2%
FMA
48
FNY Managed Accounts
New York
$165K +$180K +1,300 New
PRCM
49
Pine River Capital Management
Minnesota
$162K -$1.94K -14 -1%
Brown Advisory
50
Brown Advisory
Maryland
$152K

TNDM Hedge Fund Activity: Q4 2014 in Review

66 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Tandem Diabetes Care (TNDM) for Q4 2014, worth a combined $160M — down 5.4% from $170M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of TNDM and 13 opened new positions — a net loss of 1 holder — while 21 trimmed existing stakes and 21 added.

The largest buyer was BlackRock Advisors, adding an estimated $5.74M. The largest seller was Jennison Associates, cutting an estimated $7.93M.

  • 66 institutional investors held Tandem Diabetes Care (TNDM) as of Q4 2014, down from 69 in Q3 2014.
  • Funds reported $160M of Tandem Diabetes Care stock for Q4 2014, down 5.4% quarter-over-quarter.
  • 13 funds opened new Tandem Diabetes Care positions in Q4 2014 and 14 closed out, a net change of -1 holder.
  • The largest Tandem Diabetes Care buyer in Q4 2014 was BlackRock Advisors, an estimated $5.74M added.
  • The largest Tandem Diabetes Care seller in Q4 2014 was Jennison Associates, an estimated $7.93M sold.

Based on aggregated 13F filings for Q4 2014.